Gender
Visit vs Sp02 Range/Position: 80-89% Non-Supine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 24.9 | ± 46.2 | 8.7 | 0.0 | 368.1 | 2 | 318 |
Final | 275 | 14.5 | ± 39.0 | 2.2 | 0.0 | 386.1 | 26 | 301 |
Treatment Arm vs Sp02 Range/Position: 80-89% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 24.9 | ± 46.2 | 8.7 | 0.0 | 368.1 | 2 | 318 |
HLSE | 106 | 24.2 | ± 46.8 | 9.2 | 0.0 | 368.1 | - | 106 |
HLSE-O | 105 | 24.0 | ± 40.2 | 9.7 | 0.0 | 284.0 | 1 | 106 |
HLSE-P | 105 | 26.6 | ± 51.3 | 8.0 | 0.0 | 291.3 | 1 | 106 |
Treatment Arm vs Sp02 Range/Position: 80-89% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 14.5 | ± 39.0 | 2.2 | 0.0 | 386.1 | 25 | 300 |
HLSE | 94 | 22.0 | ± 45.2 | 7.3 | 0.0 | 279.2 | 6 | 100 |
HLSE-O | 95 | 9.0 | ± 21.7 | 0.3 | 0.0 | 159.4 | 6 | 101 |
HLSE-P | 86 | 12.6 | ± 45.3 | 0.6 | 0.0 | 386.1 | 13 | 99 |
Age vs Sp02 Range/Position: 80-89% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 24.9 | ± 46.2 | 8.7 | 0.0 | 368.1 | 2 | 318 |
45-54 years | 52 | 18.3 | ± 29.8 | 7.6 | 0.0 | 169.1 | 1 | 53 |
55-64 years | 139 | 28.3 | ± 50.6 | 11.5 | 0.0 | 368.1 | - | 139 |
65-74 years | 120 | 23.1 | ± 45.8 | 7.7 | 0.0 | 284.0 | 1 | 121 |
75 or older | 5 | 44.9 | ± 68.4 | 26.1 | 0.0 | 164.2 | - | 5 |
Age vs Sp02 Range/Position: 80-89% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 14.5 | ± 39.0 | 2.2 | 0.0 | 386.1 | 25 | 300 |
45-54 years | 42 | 9.2 | ± 18.0 | 1.9 | 0.0 | 90.4 | 7 | 49 |
55-64 years | 117 | 19.4 | ± 51.9 | 3.3 | 0.0 | 386.1 | 10 | 127 |
65-74 years | 112 | 10.4 | ± 24.2 | 1.3 | 0.0 | 167.1 | 7 | 119 |
75 or older | 4 | 45.9 | ± 76.5 | 12.1 | 0.0 | 159.4 | 1 | 5 |
Gender vs Sp02 Range/Position: 80-89% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 24.9 | ± 46.2 | 8.7 | 0.0 | 368.1 | 2 | 318 |
Male | 232 | 21.2 | ± 39.9 | 8.7 | 0.0 | 368.1 | 2 | 234 |
Female | 84 | 35.2 | ± 59.3 | 9.0 | 0.0 | 291.3 | - | 84 |
Gender vs Sp02 Range/Position: 80-89% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 14.5 | ± 39.0 | 2.2 | 0.0 | 386.1 | 26 | 301 |
Male | 202 | 13.9 | ± 35.4 | 1.4 | 0.0 | 279.2 | 20 | 222 |
Female | 73 | 16.4 | ± 48.0 | 3.0 | 0.0 | 386.1 | 6 | 79 |
Race vs Sp02 Range/Position: 80-89% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 24.9 | ± 46.2 | 8.7 | 0.0 | 368.1 | 2 | 318 |
African American or Black | 41 | 23.5 | ± 48.2 | 9.0 | 0.0 | 284.0 | 1 | 42 |
Caucasian | 251 | 25.9 | ± 46.0 | 10.0 | 0.0 | 368.1 | 1 | 252 |
Other | 24 | 16.9 | ± 45.6 | 2.1 | 0.0 | 210.4 | - | 24 |
Race vs Sp02 Range/Position: 80-89% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 14.5 | ± 39.0 | 2.2 | 0.0 | 386.1 | 25 | 300 |
African American or Black | 34 | 6.9 | ± 12.1 | 2.2 | 0.0 | 49.9 | 6 | 40 |
Caucasian | 219 | 16.7 | ± 43.2 | 2.5 | 0.0 | 386.1 | 18 | 237 |
Other | 22 | 4.5 | ± 7.3 | 2.1 | 0.0 | 31.0 | 1 | 23 |